CD38 and Miyoshi myopathy: Taken together, CD38 deletion in NK cells augments DARA-mediated ADCC of MM target cells in vitro by overcoming DARA-mediated fratricide, which enables NK cells to persist at significantly higher levels in vivo in DARA-treated mice.